본문으로 건너뛰기
← 뒤로

The Impact of Body Mass Index on Breast Reduction Outcomes: A Multi-Institutional Data Analysis of 45,000 Cases over 15 Years.

Aesthetic plastic surgery 2025 Vol.49(13) p. 3688-3702 피인용 1회 🌐 cited 12 Cancer Risks and Factors
TL;DR A significant correlation between elevated BMI and the occurrence of both surgical and medical complications after breast reduction surgery is revealed and is essential for informing preoperative counseling, refining risk assessment, and developing tailored protocols.
📈 연도별 인용 (2025–2026) · 합계 12
OpenAlex 토픽 · Cancer Risks and Factors Breast Implant and Reconstruction Global Cancer Incidence and Screening

Knoedler S, Matar DY, Kosyk M, Perozzo FAG, Sofo G, Manente M, Vafa AZ, Boroumand S, Alfertshofer M, Orgill DP, Kim BS, Panayi AC

관련 도메인

📝 환자 설명용 한 줄

A significant correlation between elevated BMI and the occurrence of both surgical and medical complications after breast reduction surgery is revealed and is essential for informing preoperative coun

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 61
  • p-value p < 0.001

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Samuel Knoedler, Dany Y. Matar, et al. (2025). The Impact of Body Mass Index on Breast Reduction Outcomes: A Multi-Institutional Data Analysis of 45,000 Cases over 15 Years.. Aesthetic plastic surgery, 49(13), 3688-3702. https://doi.org/10.1007/s00266-025-04743-w
MLA Samuel Knoedler, et al.. "The Impact of Body Mass Index on Breast Reduction Outcomes: A Multi-Institutional Data Analysis of 45,000 Cases over 15 Years.." Aesthetic plastic surgery, vol. 49, no. 13, 2025, pp. 3688-3702.
PMID 40000470

Abstract

[BACKGROUND] The caseload of breast reduction is on the rise. Despite this popularity, the association between body mass index (BMI) and postoperative outcomes remains unclear. We hypothesize that BMI is a significant determinant of postoperative morbidity after breast reduction and leverage a multi-institutional database to investigate this correlation.

[METHODS] We queried the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) (2008-2022) to identify female adult patients who underwent breast reduction. We categorized all patients into six BMI subgroups, and compared their outcomes (i.e., 30-day surgical and medical complications, reoperation, readmission, and mortality) via multivariate logistic regression analyses.

[RESULTS] 45,373 patients (mean age: 40 ± 14 years; mean BMI: 31 ± 6.1 kg/m) were identified, of whom 0.1% (n = 61) were underweight, 12% (n = 5635) healthy weight, 34% (n = 15,346) overweight, 30% (n = 13,795) had obesity I, 15% (n = 6843) obesity II, and 8.1% (n = 3693) obesity III. Overall, 2881 (6.4%) patients experienced complications, with 1936 (4.3%) cases of surgical complications and 317 (0.7%) cases of medical complications. The risk for complications increased stepwise above the healthy BMI range. Compared to women with healthy weight, patients with obesity I, II, and III had a significantly higher risk of any complication (OR 1.5, p < 0.001; OR 1.87, p < 0.001; and OR 2.6, p < 0.001, respectively), medical complications (OR 2.4, p = 0.005; OR 2.99, p = 0.001; and OR 5.2, p < 0.001, respectively), and surgical complications (OR 2.2, p < 0.001; OR 2.81, p < 0.001; and OR 4.2, p < 0.001, respectively). Overweight patients were also at higher risk for any complication (OR 1.2, p = 0.09), medical complications (OR 2.1, p = 0.02), and surgical complications (OR 1.4, p = 0.004). The odds for reoperation did not increase with higher BMI classes.

[CONCLUSION] Our multi-institutional data analysis revealed a significant correlation between elevated BMI and the occurrence of both surgical and medical complications after breast reduction surgery. The postoperative risk increased progressively with BMI above the healthy range. These findings are essential for informing preoperative counseling, refining risk assessment, and developing tailored protocols.

[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors  www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 breast reduction 유방성형술 dict 5
해부 breast 유방 dict 5
약물 [BACKGROUND] The scispacy 1
약물 [RESULTS] 45,373 patients scispacy 1
질환 obesity C0028754
Obesity
scispacy 1
질환 obesity II C0028754
Obesity
scispacy 1
질환 Overweight C0497406
Overweight
scispacy 1
기타 female scispacy 1
기타 women scispacy 1

MeSH Terms

Humans; Female; Body Mass Index; Adult; Postoperative Complications; Mammaplasty; Middle Aged; Retrospective Studies; Treatment Outcome; Databases, Factual; Obesity; United States; Risk Assessment; Reoperation

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

같은 제1저자의 인용 많은 논문 (5)

관련 논문